4D Molecular Therapeutics (FDMT)

• Market cap: $433M
• 1 day: -1.3%
• 5 days: -11.96%
• 1 month: -27.88%
• 3 months: -12.77%
• 6 months: 104.31%
• Year to date: 30.02%
• 1 year: 43.02%
• 5 years: -81.8%
• 10 years: -81.28%
• Sector: Healthcare
• Industry: Biotechnology

About: 4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Employees: 227